# Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer

> **NCT02015754** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 14 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** DEBIRI
- **DEVICE:** LC Bead M1
- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT02015754
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-06-02
- **Final completion:** 2016-12-13
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02015754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02015754, "Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02015754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*